Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Br J Haematol. 2017 Sep 7;179(4):648–656. doi: 10.1111/bjh.14918

Figure 2. Brachial artery flow.

Figure 2

Calculated brachial artery flow in controls, SCD patients not on HC and SCD patients on HC therapy demonstrates no significant differences between groups. HC: hydroxycarbamide; ns: not significant; SCD: sickle cell disease.